Journal of the National Comprehensive Cancer Network · 2014 · 107 citations · 33 references
MedicineOncologyUrologyEarly DetectionGenitourinary OncologyProstate DiseaseCancer Early DetectionEarly Cancer DetectionProstate BiopsyProstate CancerProstate HealthProstate-specific Antigen TestingBiomarkersBiopsy Of Prostate LesionsProstate Cancer DiagnosisProstate Cancer Risk StratificationProstate Health IndexProstate ScreeningRisk Stratification For Biopsy
The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.
33
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text
G. L. Andriole, E. David Crawford, Robert L. Grubb et al. · JNCI Journal of the National Cancer Institute · 2012 · 1.1K citations · Full text